244 related articles for article (PubMed ID: 34713248)
1. Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies.
Mussolino C; Strouboulis J
Front Genome Ed; 2021; 3():618111. PubMed ID: 34713248
[TBL] [Abstract][Full Text] [Related]
2. A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies.
Zittersteijn HA; Harteveld CL; Klaver-Flores S; Lankester AC; Hoeben RC; Staal FJT; Gonçalves MAFV
Front Genome Ed; 2020; 2():617780. PubMed ID: 34713239
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing.
Fontana L; Alahouzou Z; Miccio A; Antoniou P
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980849
[TBL] [Abstract][Full Text] [Related]
4. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers in hemoglobinopathies.
Rund D; Fucharoen S
Curr Mol Med; 2008 Nov; 8(7):600-8. PubMed ID: 18991646
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
7. Treating hemoglobinopathies using gene-correction approaches: promises and challenges.
Cottle RN; Lee CM; Bao G
Hum Genet; 2016 Sep; 135(9):993-1010. PubMed ID: 27314256
[TBL] [Abstract][Full Text] [Related]
8. Engineering Globin Gene Expression.
Davis R; Gurumurthy A; Hossain MA; Gunn EM; Bungert J
Mol Ther Methods Clin Dev; 2019 Mar; 12():102-110. PubMed ID: 30603654
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
10. β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies.
Barbarani G; Łabedz A; Ronchi AE
Front Genome Ed; 2020; 2():571239. PubMed ID: 34713219
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing for β-Hemoglobinopathies: Advances and Challenges.
Frati G; Miccio A
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33525591
[TBL] [Abstract][Full Text] [Related]
12. Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies.
Perrine SP; Pace BS; Faller DV
Hematol Oncol Clin North Am; 2014 Apr; 28(2):233-48. PubMed ID: 24589264
[TBL] [Abstract][Full Text] [Related]
13. Animal models of β-hemoglobinopathies: utility and limitations.
McColl B; Vadolas J
J Blood Med; 2016; 7():263-274. PubMed ID: 27853395
[TBL] [Abstract][Full Text] [Related]
14. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.
Perrine SP; Faller DV
Experientia; 1993 Feb; 49(2):133-7. PubMed ID: 7680003
[TBL] [Abstract][Full Text] [Related]
15. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.
Costa D; Capuano M; Sommese L; Napoli C
Blood Cells Mol Dis; 2015 Aug; 55(2):95-100. PubMed ID: 26142322
[TBL] [Abstract][Full Text] [Related]
16. Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran.
Fakher R; Bijan K; Taghi AM
Indian J Hum Genet; 2007 Jan; 13(1):5-15. PubMed ID: 21957335
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hemoglobinopathies: progress and challenges.
Dong A; Rivella S; Breda L
Transl Res; 2013 Apr; 161(4):293-306. PubMed ID: 23337292
[TBL] [Abstract][Full Text] [Related]
18. Recent advance on genome editing for therapy of β-hemoglobinopathies.
Liu JW; Hong T; Qin X; Liang YM; Zhang P
Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902
[TBL] [Abstract][Full Text] [Related]
19. Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies.
Demirci S; Leonard A; Tisdale JF
Hum Mol Genet; 2020 Sep; 29(R1):R100-R106. PubMed ID: 32406490
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin genetics: recent contributions of GWAS and gene editing.
Smith EC; Orkin SH
Hum Mol Genet; 2016 Oct; 25(R2):R99-R105. PubMed ID: 27340226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
